Triamcinolone hexacetonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C30H41FO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I7GT1U99Y9, chemically known as 9-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-(3,3-dimethylbutyrate) but more generally known as triamcinolone hexacetonide, which bears US NIH Compound Identifier 21826. European Medicines Agency schedules Triamcinolone hexacetonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11254MIG. The term TRIAMCINOLONE HEXACETONIDE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule triamcinolone hexacetonide under HS 29372200 and SITC 54153. As of Q4 2014, TRIAMCINOLONE HEXACETONIDE remains US FDA's Preferred Term for this commodity. Triamcinolone hexacetonide bears US NLM identifiers UMLS ID C0077004 and NCI Concept Code C48026. SMILES: C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)COC(=O)CC(C)(C)C)CCC5=CC(=O)C=C[C@@]53C)F)O.